(19) The two brominated compounds in the FM 550 formulation were detected at lower concentrations than TDCPP and PentaBDE, likely because they are parts of a mixture.
Thermal degradation of the formulations was detected over a wide range with several weight loss steps evident on derivative thermograms.
Highest gene expression was detected from CO3Ap formulations prepared with 6 μL CaCl2 for transfection in medium with serum) and 8 μL CaCl2 for transfection in serum-free medium and 1(c)).
Percentages and numbers of Eα/MHCII positive DCs equivalent to soluble and 40 nm particle antigen formulations were detected at 24 and 48 hr.
No interference from the formulation ingredients was detected.
Plasma levels of carboxyfluorescein after oral MS administration proved a sustained release in a rat model, where Cmax of carboxyfluorescein solution was found at around 60 min while for MS formulations it was detected after 4 h.
Over this parameter, a significant sex-by-formulation interaction was detected: 90CI CMAX T/R was 0.838 1.36 in women and 0.540 0.920 in men; with a 52% relative difference between point estimates.
The highest concentration was observed in the conjunctiva at 0.5 1 h in both formulations, and the lowest was detected after 4 h.
Following 5 injections (3 days apart), a significant antitumor effect of miR-34a SNALPs formulation (SNALP 1) versus the control was detected).
However, no melting peak was detected for both nanoparticle formulations.
